- Home
- CRDF vs CTEV Comparison
CRDF vs CTEV Comparison
Compare CRDF & CTEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- CTEV
- Stock Information
- Founded
- CRDF 1999
- CTEV 1980
- Country
- CRDF United States
- CTEV United States
- Employees
- CRDF N/A
- CTEV N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- CTEV
- Sector
- CRDF Health Care
- CTEV
- Exchange
- CRDF Nasdaq
- CTEV NYSE
- Market Cap
- CRDF 196.2M
- CTEV 371.3M
- IPO Year
- CRDF N/A
- CTEV N/A
- Fundamental
- Price
- CRDF $2.63
- CTEV $21.58
- Analyst Decision
- CRDF Strong Buy
- CTEV Hold
- Analyst Count
- CRDF 4
- CTEV 1
- Target Price
- CRDF $12.00
- CTEV $19.00
- AVG Volume (30 Days)
- CRDF 1.1M
- CTEV 54.7K
- Earning Date
- CRDF 05-20-2025
- CTEV 05-08-2025
- Dividend Yield
- CRDF N/A
- CTEV N/A
- EPS Growth
- CRDF N/A
- CTEV N/A
- EPS
- CRDF N/A
- CTEV N/A
- Revenue
- CRDF $683,000.00
- CTEV $927,446,000.00
- Revenue This Year
- CRDF N/A
- CTEV $2.18
- Revenue Next Year
- CRDF N/A
- CTEV $3.04
- P/E Ratio
- CRDF N/A
- CTEV N/A
- Revenue Growth
- CRDF 39.96
- CTEV N/A
- 52 Week Low
- CRDF $2.01
- CTEV $4.80
- 52 Week High
- CRDF $5.64
- CTEV $31.00
- Technical
- Relative Strength Index (RSI)
- CRDF 41.22
- CTEV N/A
- Support Level
- CRDF $2.42
- CTEV N/A
- Resistance Level
- CRDF $2.87
- CTEV N/A
- Average True Range (ATR)
- CRDF 0.18
- CTEV 0.00
- MACD
- CRDF 0.01
- CTEV 0.00
- Stochastic Oscillator
- CRDF 24.42
- CTEV 0.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About CTEV CLARITEV CORPORATION
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.